You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

axonal degeneration

Showing 1 - 25 of 1,902
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Study to Assess OCT: RNFL and GCL in MS Patients

Completed
  • Multiple Sclerosis
    • New Port Richey, Florida
    • +1 more
    May 30, 2021

    Gender Dysphoria Trial in Nashville (Polyethylene Glycol 3350)

    Recruiting
    • Gender Dysphoria
    • Polyethylene Glycol 3350
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Jun 1, 2023

    Neurodegenerative Process Within Visual Ways In Multiple

    Completed
    • Multiple Sclerosis
      • Lille, France
        Hôpital Roger Salengro, CHRU
      Sep 20, 2022

      Insulin Resistance in Egyptian Patients With Multiple Sclerosis

      Not yet recruiting
      • Multiple Sclerosis
      • Insulin Resistance
      • treatment of insulin resistance with appropriate modality according to each patient
      • (no location specified)
      Aug 28, 2023

      Imaging Interplay Between Axonal Damage and Repair in Multiple

      Recruiting
      • Multiple Sclerosis (MS)
      • +3 more
      • MRI
      • +2 more
      • Basel, Switzerland
        University Hospital Basel, Department of Neurology
      Dec 15, 2021

      Macrophages Activation Pattern in X-linked Adrenoleukodystrophy,

      Recruiting
      • Adrenoleukodystrophy
      • +3 more
      • Blood sample collection
      • Le Kremlin-Bicêtre, France
      • +1 more
      Oct 10, 2022

      Inflammatory Disease in Multiple Sclerosis

      Active, not recruiting
      • Relapsing Multiple Sclerosis
      • Multiple Sclerosis
      • Cerebrospinal and Blood Serum Semaphorin 4A Levels
      • Portland, Oregon
        Providence St. Vincent Medical Center
      May 19, 2022

      TRACK-TBI Longitudinal Biomarker Study

      Enrolling by invitation
      • Traumatic Brain Injury
      • Telephone Outcome Assessment
      • +3 more
      • San Francisco, California
      • +10 more
      May 31, 2022

      Alzheimer's Disease (Incl Subtypes), Dementia Trial in Boston (MIB-626, Placebo)

      Recruiting
      • Alzheimer's Disease (Incl Subtypes)
      • Dementia
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Jul 11, 2022

      Secondary-progressive Multiple Sclerosis Trial in Buffalo (Mayzent, Ocrevus)

      Recruiting
      • Secondary-progressive Multiple Sclerosis
      • Buffalo, New York
        University at Buffalo, Buffalo General Hospital
      Oct 10, 2022

      Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

      Recruiting
      • Rare Disorders
      • +309 more
        • Sioux Falls, South Dakota
        • +1 more
        Jun 20, 2022

        CIPN - Chemo-Induced Peripheral Neuropathy Trial in Lebanon (EPR Oximetry)

        Active, not recruiting
        • CIPN - Chemotherapy-Induced Peripheral Neuropathy
        • EPR Oximetry
        • Lebanon, New Hampshire
          Dartmouth-Hitchcock Medical Center in Lebanon, NH
        Feb 17, 2022

        Neurodegenerative Disease, Hereditary, Mitochondrial Diseases, Optic Atrophy Trial in Buffalo (Mutation analysis)

        Recruiting
        • Neurodegenerative Disease, Hereditary
        • +2 more
        • Mutation analysis
        • Buffalo, New York
          UBMD Pediatrics
        Mar 3, 2022

        Glaucoma, Glaucoma Eye, Glaucoma, Open-Angle Trial in San Antonio (dietary supplement, drug, other)

        Withdrawn
        • Glaucoma
        • +2 more
        • Lumega-Z
        • +2 more
        • San Antonio, Texas
          Ophtalmology Clinic of William E Sponsel
        Sep 30, 2022

        Multiple Sclerosis Trial (imaging of energy dysfunction)

        Not yet recruiting
        • Multiple Sclerosis
        • imaging of energy dysfunction
        • (no location specified)
        Aug 26, 2020

        I-Tracking Neurodegeneration in Early Wolfram Syndrome

        Recruiting
        • Wolfram Syndrome
          • Saint Louis, Missouri
            Washington University School of Medicine
          Jun 6, 2022

          Anti-Argonaute Antibodies for Diagnosis of Sensory

          Completed
          • Autoimmune Diseases
          • Diagnosis of sensitive neuronopathy - phase 1
          • +4 more
          • Saint-Étienne, France
            CHU Saint-Etienne
          Jul 27, 2023

          Amyotrophic Lateral Sclerosis

          Completed
          • Amyotrophic Lateral Sclerosis
          • LMND-ALS
          • +2 more
          • Beijing, China
            Peking University Third Hospital
          Jul 1, 2020

          Distal Radius Fracture, Vitamine c, Prophylaxis Trial in Damascus (Vitamin C, Placebo)

          Not yet recruiting
          • Distal Radius Fracture
          • +2 more
          • Vitamin C
          • Placebo
          • Damascus, Syrian Arab Republic
            Damascus university
          Apr 24, 2023

          Chemo-induced Peripheral Neuropathy, Breast Cancer Metastatic, Platinum-resistant Recurrent Ovarian Cancer Trial in Iowa City,

          Recruiting
          • Chemotherapy-induced Peripheral Neuropathy
          • +2 more
          • Nicotinamide Riboside
          • Iowa City, Iowa
          • +1 more
          Apr 26, 2021

          Multiple System Atrophy Trial in Rochester (Autologous Mesenchymal Stem Cells, Placebo)

          Recruiting
          • Multiple System Atrophy
          • Autologous Mesenchymal Stem Cells
          • Placebo
          • Rochester, Minnesota
            Mayo Clinic
          Jan 18, 2022

          Multiple Sclerosis, Sclerosis, Demyelinating Diseases Trial in Portland (Aerobic exercise, Education Group Control)

          Recruiting
          • Multiple Sclerosis
          • +6 more
          • Aerobic exercise
          • Education Group Control
          • Portland, Oregon
            Oregon Health & Science University
          Aug 8, 2022

          Glaucoma Trial in Montréal (Topic insulin (4 units), Topic insulin (20 units))

          Suspended
          • Glaucoma
          • Topic insulin (4 units)
          • Topic insulin (20 units)
          • Montréal, Quebec, Canada
            Centre Hospitalier de l'Université de Montréal
          Aug 16, 2021

          Cerebrospinal Fluid Immunoglobulin Free Light Chains in Multiple

          Recruiting
          • Multiple Sclerosis
          • CSF immunoglobulin (Ig) free light chains (FLC) dosage
          • Brussels, Belgium
            CHU Brugmann
          Sep 28, 2021

          Parkinson's Disease and Parkinsonism Trial (DBS)

          Not yet recruiting
          • Parkinson's Disease and Parkinsonism
          • DBS
          • (no location specified)
          Jun 28, 2023